Testing effectiveness (Phase 2)Looking for participantsNCT07787273
What this trial is testing
Interferon Gamma Plus Camrelizumab as Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Who this might be right for
Locally Advanced Esophageal Squamous Cell CarcinomaNeoadjuvant TherapyCamrelizumab
Hefei Cancer Hospital of the Chinese Academy of Sciences 84